The BE CARING Study is gathering information on bimekizumab in the breast milk of breastfeeding mothers, who are taking this drug for their autoimmune or autoinflammatory disease.
This UCB website uses cookies. Some of these cookies are necessary for the proper functioning of this website (functional cookies) and relate to managing user preferences and website security. Functional cookies cannot be refused when you choose to visit this website. We would also like to set other – optional – cookies for user experience enhancement, website improvement and analytics. For more information on these cookies, please see our Cookie Policy. We will not deploy optional cookies unless you consent to their use. To grant your consent to all optional cookies at once, please click on the “Accept” button below. If you click on “Deny all” or if you close this banner without specifying your preference, we will not set any optional cookies on your device. To manage your cookie preferences, including to withdraw your consent, please refer to and adjust your browser settings as explained in our Cookie Policy, accessible here.
